M Poe

Dihydrofolate reductase: x-ray structure of the binary complex with methotrexate.

N. Xuong, J. Bolin, D. Matthews, 1977, Science.

Quantitative structure-activity relationships for the inhibition of Escherichia coli dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines.

R. Li, M. Poe, M Poe, 1988, Journal of medicinal chemistry.

On the optimization of hydrophobic and hydrophilic substituent interactions of 2,4-diamino-5-(substituted-benzyl)pyrimidines with dihydrofolate reductase.

C. Hansch, C. Selassie, M. Poe, 1991, Journal of medicinal chemistry.

Human cytotoxic lymphocyte granzyme B. Its purification from granules and the characterization of substrate and inhibitor specificity.

N H Sigal, N. Sigal, M. Poe, 1991, The Journal of biological chemistry.

Methotrexate binding to dihydrofolate reductase from a methotrexate-resistant strain of Escherichia coli.

M. N. Williams, N J Greenfield, N. Greenfield, 1973, The Journal of biological chemistry.

Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules.

J B Gibbs, E. Scolnick, I. Sigal, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Calculations by complete neglect of differential overlap (CNDO/2) on dihydrofolic acid: role of N(5) in reduction by dihydrofolate reductase.

P. Gund, M. Poe, M Poe, 1977, Molecular pharmacology.